Target intelligence / Profile preview

Cadherin 9 (CDH9)

Target
CDH9
Molecular classification
Cadherin superfamily, Type II classical cadherin, Cell adhesion molecule, Single-pass transmembrane protein
01

Overview

Cadherin 9 is a type II classical cadherin protein and is encoded by the CDH9 gene in humans. It is an integral single-pass transmembrane glycoprotein of the cadherin superfamily, mediating calcium-dependent cell-cell adhesion through homophilic interactions. The protein consists of an extracellular domain with five cadherin motifs, a transmembrane domain, and a conserved cytoplasmic tail. Cadherin 9 is highly expressed in dentate gyrus (DG) and CA3 neurons in the hippocampus, where it plays a critical role in the formation, differentiation, and maintenance of specific excitatory synaptic connections—particularly DG-CA3 mossy fiber synapses—by recruiting β-catenin and organizing synaptic structure. Disruption of CDH9 is linked to synaptic defects, neurodevelopmental disorders like autism, and may also act as a metastasis suppressor in some cancers[1][2][3][4].

Other names
CDH9CADH9cadherin-9clustered protocadherin-9
02

Biological functions

Cell-cell adhesionSynapse formationNeural circuit differentiationCalcium-dependent homophilic bindingIntracellular signaling via catenins
03

Disease associations

Autism spectrum disorderCancer metastasis suppressionChromosome 16p11.2 deletion syndromeCraniofacial-deafness-hand syndrome
04

Biomarkers

Fibroblast surface marker

Beyond the preview

Go deeper on Cadherin 9 (CDH9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cadherin 9 (CDH9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call